{"brand":"Compound Laws","url":"https://compoundlaws.com/compounds/blue-lotus/vermont/","compound":{"slug":"blue_lotus","name":"Blue Lotus (Nymphaea caerulea)","same_as":"https://en.wikipedia.org/wiki/Nymphaea_caerulea"},"jurisdiction":{"code":"VT","name":"Vermont"},"as_of":"2026-10-25","answer":"As of October 25, 2026, Blue Lotus (Nymphaea caerulea) is legal to sell at retail in Vermont. Not scheduled; no named ban or consumption restriction. Controlling source: 18 V.S.A. Sec. 4201(10) (definition of 'Hallucinogenic drugs'); schedules delegated under Sec. 4202 / ch. 84.","forms":[{"form":"all","label":"All forms","status":"legal","state_status":null,"federal_overlay":false,"headline":"Not scheduled; no named ban or consumption restriction","rule_type":"permanent","tier":"unscheduled","schedule_class":null,"limit":null,"effective_date":null,"verified_at":"2026-10-25","confidence":"under_review","verbatim_excerpt":"'Hallucinogenic drugs' means stramonium, mescaline or peyote, lysergic acid diethylamide, and psilocybin, and all synthetic equivalents of chemicals contained in resinous extractives of Cannabis sativa, or any salts or derivatives or compounds of any preparations or mixtures thereof, and any other substance that is designated as habit-forming or as having a serious potential for abuse arising out of its effect on the central nervous system or its hallucinogenic effect in the rules adopted by the Department of Health under section 4202 of this title.","excerpt_source_url":"https://legislature.vermont.gov/statutes/section/18/084/04201","citations":[{"title":"18 V.S.A. Sec. 4201(10) (definition of 'Hallucinogenic drugs'); schedules delegated under Sec. 4202 / ch. 84","url":"https://legislature.vermont.gov/statutes/section/18/084/04201","pinpoint":null,"publisher":"Vermont General Assembly","type":"statute","primary":true,"official":true}],"history":[]}],"neighbors":[{"code":"MA","status":"legal"},{"code":"NH","status":"legal"},{"code":"NY","status":"legal"}],"laws":[{"citation":"18 V.S.A. 4201(10) (hallucinogenic drugs definition; schedules delegated to Dept. of Health rule under 4202)","title":"18 V.S.A. 4201(10) (hallucinogenic drugs definition; schedules delegated to Dept. of Health rule under 4202)","official_url":"https://legislature.vermont.gov/statutes/section/18/084/04201","source_label":"OFFICIAL","effective_date":null,"retrieved_date":"2026-10-08","text_hash":"c6f707ea9b84197e25a4ba74d480c3cee3434b10457aba33cf1b12c7ca367954"},{"citation":"Vermont Regulated Drug Rule (Dept. of Health), § 7.0 (Hallucinogenic Drugs; Tryptamines), under 18 V.S.A. §§ 4201–4202","title":null,"official_url":"https://www.healthvermont.gov/sites/default/files/documents/pdf/REG_regulated-drugs.pdf","source_label":"OFFICIAL","effective_date":null,"retrieved_date":"2026-06-19","text_hash":"011afd53c5b60e2b50eb111fa4acb70719ac3f5a748e454768f73124d2086d09"},{"citation":"Vermont Regulated Drug Rule Sec. 7.0 (18 V.S.A. Sec. 4201-4202; Sec. 4230-4237)","title":"Regulated Drug Rule Sec. 7.0 - Hallucinogenic Drugs; Synthetic Cannabinoids; Tryptamines; Cannabinimimetics; Mescaline Analogs; Dissociatives (named entry: 5-MAPB)","official_url":"https://www.healthvermont.gov/sites/default/files/documents/pdf/REG_regulated-drugs.pdf","source_label":"OFFICIAL","effective_date":null,"retrieved_date":"2026-07-20","text_hash":"dd18e4f4abf49a55e17735355462887e99d9e2b2ff449b1d85e960cd38795ab2"}]}